Thus, we suppose the predictive role of AMH is different in ovarian responsiveness to ovulation induction with CC and ovarian hyperstimulation with gonadotrophins for IVF treatment, because the goal of stimulation in women with anovulation is different than that in women undergoing IVF. This evidence concerns the gene AMH and anovulation.